Virtus LifeSci Profile

26.00
USD 0.13  0.51%

Virtus LifeSci Summary

Virtus LifeSci Biotech Clinical Trls ETF [BBC] is traded in USA and was established 2014-12-16. The fund is classified under Health category within Virtus family. Virtus LifeSci Biotech currently have 26.29M in assets under management (AUM). , while the total return for the last 3 years was 9.67%.
Check Virtus LifeSci Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

Top Etf Constituents

Virtus LifeSci Target Price Odds Analysis

Odds Below 26.0HorizonTargetOdds Above 26.0
84.33%30 days 26.00 15.53%
Based on normal probability distribution, the odds of Virtus LifeSci to move above current price in 30 days from now is about 15.53% (This Virtus LifeSci Biotech Clinical Trls ETF probability density function shows the probability of Virtus LifeSci Etf to fall within a particular range of prices over 30 days) .

Virtus LifeSci Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Lpl Financial LlcFund Units30.5 K708 K
View Virtus LifeSci Diagnostics

Virtus LifeSci Biotech Risk Profiles

Virtus LifeSci Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of thirty-nine. Virtus LifeSci Biotech Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Virtus LifeSci price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Virtus LifeSci Key Fundamentals

Virtus LifeSci Against Markets

Virtus LifeSci Current Ratings

Virtus LifeSci Biotech Clinical Trls ETF 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
15
Chance of
Financial Distress (0 to 100%)
54%
Equity ratings for Virtus LifeSci Biotech Clinical Trls ETF are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Virtus LifeSci is traded on Archipelago Exchange in USA. more
NameVirtus LifeSci Biotech Clinical Trls ETF
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerVirtus
ExchangeArchipelago Exchange
Etf FamilyVirtus
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone888 383 0553
CurrencyUSD - US Dollar
IssuerVirtus
DescriptionVirtus LifeSci Biotech Clinical Trials ETF
Inception Date2014-12-17
BenchmarkLifeSci Biotechnology Clinical Trials Index
Entity TypeRegulated Investment Company
Asset Under Management57.7 Million
Average Trading Valume8,846
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorVirtus ETF Solutions LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Portfolio ManagerMatthew B. Brown, Seth Kadushin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year EndOctober 31
ExchangeNYSE Arca, Inc.
Number of Constituents97.0
Market MakerVirtu Financial
Total Expense0.79
Management Fee0.79
Nav Price26.44
Two Hundred Day Average28.7606
Ytd7.86%
Average Daily Volume In Three Month12.36k
Fifty Two Week Low20.22
Average Daily Volume Last 10 Day4.1k
Fifty Two Week High36.25
One Month7.86%
Fifty Day Average25.0691
Three Month-6.63%
Beta In Three Year1.83

Current Sentiment - BBC

Virtus LifeSci Biotech Investor Sentiment

Greater number of Macroaxis users are currently bullish on Virtus LifeSci Biotech Clinical Trls ETF. What is your outlook on investing in Virtus LifeSci Biotech Clinical Trls ETF? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip
Check also Trending Equities. Please also try Coins and Tokens Correlation module to utilize digital token correlation table to build portfolio of cryptocurrencies across multiple exchanges.
Search macroaxis.com